DNA damage induces targeted, genome-wide variation of poly(A) sites in budding yeast

Genome Research

Volumn 23, Issue 10, 2013, Pages 1690-1703

  Graber, Joel H ^a   Nazeer, Fathima I ^b   Yeh, Pei Chun ^b   Kuehner, Jason N ^b,c   Borikar, Sneha ^a,b   Hoskinson, Derick ^b   Moore, Claire L ^b  

^a JACKSON LABORATORY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMMANUEL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CELL EXTRACT; CIS ACTING ELEMENT; DNA; MESSENGER RNA; POLYADENYLIC ACID; RNA ISOFORM;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENE CONTROL; GENE STRUCTURE; GENETIC VARIABILITY; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; RNA PROCESSING; SACCHAROMYCES CEREVISIAE; ULTRAVIOLET RADIATION;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; CYCLIC N-OXIDES; DNA DAMAGE; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; GENOME, FUNGAL; OPEN READING FRAMES; POLYADENYLATION; RNA ISOFORMS; RNA, FUNGAL; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ANALYSIS, RNA;

EID: 84885078620     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.144964.112     Document Type: Article

References (97)

1. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
2. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, BartelDP. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
3. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D. 2000. Patterns of variant polyadenylation signal usage in human genes. Genome Res 10: 1001-1010.
4. Beissbarth T, Speed TP. 2004. GOstat: Find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20: 1464-1465.
5. Berg MG, Singh LN, Younis I, Liu Q, Pinto AM, Kaida D, Zhang Z, Cho S, Sherrill-Mix S, Wan L, et al. 2012. U1 snRNP determines mRNA length and regulates isoform expression. Cell 150: 53-64.
6. Blattner C, Kannouche P, Litfin M, Bender K, Rahmsdorf HJ, Angulo JF, Herrlich P. 2000. UV-induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol 20: 3616-3625.
7. Borson ND, Salo WL, Drewes LR. 1992. A lock-docking oligo(dT) primer for 59 and 39 RACE PCR. PCR Methods Appl 2: 144-148.
8. Brockman JM, Singh P, Liu D, Quinlan S, Salisbury J, Graber JH. 2005. PACdb: PolyA Cleavage site and 39-UTR database. Bioinformatics 21: 3691-3693.
9. Bucheli ME, He X, Kaplan CD, Moore CL, Buratowski S. 2007. Polyadenylation site choice in yeast is affected by competition between Npl3 and polyadenylation factor CFI. RNA 13: 1756-1764.
10. Bullard JH, Purdom E, Hansen KD, Dudoit S. 2010. Evaluation of statistical methods for normalization and differential expression in mRNA-seq experiments. BMC Bioinformatics 11: 94.
11. Cevher MA, Kleiman FE. 2010. Connections between 39-end processing and DNA damage response. Wiley Interdiscip Rev RNA 1: 193-199.
12. Chan S, Choi EA, Shi Y. 2011. Pre-mRNA 39-end processing complex assembly and function. Wiley Interdiscip Rev RNA 2: 321-335.
13. Chen J, Moore C. 1992. Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA. Mol Cell Biol 12: 3470-3481.
14. Cheng H, He X, Moore C. 2004. The essential WD repeat protein Swd2 has dual functions in RNA polymerase II transcription termination and lysine 4 methylation of histone H3. Mol Cell Biol 24: 2932-2943.
15. Cui Y, Denis CL. 2003. In vivo evidence that defects in the transcriptional elongation factors RPB2, TFIIS, and SPT5 enhance upstream poly(A) site utilization. Mol Cell Biol 23: 7887-7901.
16. Decorsiere A, Cayrel A, Vagner S, Millevoi S. 2011. Essential role for the interaction between hnRNP H/F and aGquadruplex in maintaining p53 pre-mRNA 39-end processing and function during DNA damage. Genes Dev 25: 220-225.
17. Di Giammartino DC, Nishida K, Manley JL. 2011. Mechanisms and consequences of alternative polyadenylation. Mol Cell 43: 853-866.
18. Dichtl B, Keller W. 2001. Recognition of polyadenylation sites in yeast pre-mRNAs by cleavage and polyadenylation factor. EMBO J 20: 3197-3209.
19. Dichtl B, Blank D, Sadowski M, Hubner W, Weiser S, Keller W. 2002. Yhh1p/Cft1p directly links poly(A) site recognition and RNA polymerase II transcription termination. EMBO J 21: 4125-4135.
20. Eckmann CR, Rammelt C, Wahle E. 2011. Control of poly(A) tail length. Wiley Interdiscip Rev RNA 2: 348-361.
21. Fernandes AR, Mira NP, Vargas RC, Canelhas I, Sa-Correia I. 2005. Saccharomyces cerevisiae adaptation to weak acids involves the transcription factor Haa1p and Haa1p-regulated genes. Biochem Biophys Res Commun 337: 95-103.
22. Foss EJ, Radulovic D, Shaffer SA, Ruderfer DM, Bedalov A, Goodlett DR, Kruglyak L. 2007. Genetic basis of proteome variation in yeast. Nat Genet 39: 1369-1375.
23. Foss EJ, Radulovic D, Shaffer SA, Goodlett DR, Kruglyak L, Bedalov A. 2011. Genetic variation shapes protein networks mainly through nontranscriptional mechanisms. PLoS Biol 9: e1001144.
24. Garas M, Dichtl B, KellerW. 2008. The role of the putative 39 end processing endonuclease Ysh1p in mRNA and snoRNA synthesis. RNA 14: 2671-2684.
25. Ghazy MA, He X, Singh BN, Hampsey M, Moore C. 2009. The essential N terminus of the Pta1 scaffold protein is required for snoRNA transcription termination and Ssu72 function but is dispensable for pre-mRNA 39-end processing. Mol Cell Biol 29: 2296-2307.
26. Graber JH, Cantor CR, Mohr SC, Smith TF. 1999. Genomic detection of new yeast pre-mRNA 39-end-processing signals. Nucleic Acids Res 27: 888-894.
27. Graber JH, McAllister GD, Smith TF. 2002. Probabilistic prediction of Saccharomyces cerevisiae mRNA 39-processing sites. Nucleic Acids Res 30: 1851-1858.
28. Graber JH, Salisbury J, Hutchins LN, Blumenthal T. 2007. C. elegans sequences that control trans-splicing and operon pre-mRNA processing. RNA 13: 1409-1426.
29. Grant GR, Farkas MH, Pizarro AD, Lahens NF, Schug J, Brunk BP, Stoeckert CJ, Hogenesch JB, Pierce EA. 2011. Comparative analysis of RNA-seq alignment algorithms and the RNA-seq unified mapper (RUM). Bioinformatics 27: 2518-2528.
30. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R. 2002. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1: 323-333.
31. Guo Z, Sherman F. 1996a. 39-end-forming signals of yeast mRNA. Trends Biochem Sci 21: 477-481.
32. Guo Z, Sherman F. 1996b. Signals sufficient for 39-end formation of yeast mRNA. Mol Cell Biol 16: 2772-2776.
33. He X, Moore C. 2005. Regulation of yeast mRNA 39 end processing by phosphorylation. Mol Cell 19: 619-629.
34. He X, Khan AU, Cheng H, Pappas DL Jr, Hampsey M, Moore CL. 2003. Functional interactions between the transcription and mRNA 39 end processing machineries mediated by Ssu72 and Sub1. Genes Dev 17: 1030-1042.
35. Heine GF, Horwitz AA, Parvin JD. 2008. Multiple mechanisms contribute to inhibit transcription in response to DNA damage. J Biol Chem 283: 9555-9561.
36. Hu J, Lutz CS, Wilusz J, Tian B. 2005. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 11: 1485-1493.
37. Hutchins LN, Murphy SM, Singh P, Graber JH. 2008. Position-dependent motif characterization using non-negative matrix factorization. Bioinformatics 24: 2684-2690.
38. Iglesias N, Stutz F. 2008. Regulation of mRNP dynamics along the export pathway. FEBS Lett 582: 1987-1996.
39. Inada T, Aiba H. 2005. Translation of aberrant mRNAs lacking a termination codon or with a shortened 39-UTR is repressed after initiation in yeast. EMBO J 24: 1584-1595.
40. Jan CH, Friedman RC, Ruby JG, Bartel DP. 2011. Formation, regulation and evolution of Caenorhabditis elegans 39UTRs. Nature 469: 97-101.
41. Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kuhn U, Menzies FM, Vrielink JA, Bos AJ, Drost J, Rooijers K, et al. 2012. The poly(a)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149: 538-553.
42. Ji Z, Tian B. 2009. Reprogramming of 39 untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE 4: e8419.
43. Ji Z, Lee JY, Pan Z, Jiang B, Tian B. 2009. Progressive lengthening of 39 untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci 106: 7028-7033.
44. Johnson SA, Kim H, Erickson B, Bentley DL. 2011. The export factor Yra1 modulates mRNA 39 end processing. Nat Struct Mol Biol 18: 1164-1171.
45. Juge F, Audibert A, Benoit B, Simonelig M. 2000. Tissue-specific autoregulation of Drosophila suppressor of forked by alternative poly(A) site utilization leads to accumulation of the suppressor of forked protein in mitotically active cells. RNA 6: 1529-1538.
46. Kebaara BW, Atkin AL. 2009. Long 39-UTRs target wild-type mRNAs for nonsense-mediated mRNA decay in Saccharomyces cerevisiae. Nucleic Acids Res 37: 2771-2778.
47. Kleiman FE, Manley JL. 1999. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285: 1576-1579.
48. Kleiman FE, Manley JL. 2001. The BARD1-CstF-50 interaction links mRNA 39 end formation to DNA damage and tumor suppression. Cell 104: 743-753.
49. Kuersten S, Goodwin EB. 2003. The power of the 39 UTR: Translational control and development. Nat Rev Genet 4: 626-637.
50. Kyburz A, Sadowski M, Dichtl B, Keller W. 2003. The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 39-end formation. Nucleic Acids Res 31: 3936-3945.
51. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, Gartner C, Dimova N, Hanna J, Gygi SP, et al. 2010. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467: 179-184.
52. Legendre M, Gautheret D. 2003. Sequence determinants in human polyadenylation site selection. BMC Genomics 4: 7.
53. Legendre M, Ritchie W, Lopez F, Gautheret D. 2006. Differential repression of alternative transcripts: A screen for miRNA targets. PLoS Comput Biol 2: e43.
54. Lembo A, Di Cunto F, Provero P. 2012. Shortening of 39UTRs correlates with poor prognosis in breast and lung cancer. PLoS ONE 7: e31129.
55. Lutz CS, Moreira A. 2011. Alternative mRNA polyadenylation in eukaryotes: An effective regulator of gene expression. Wiley Interdiscip Rev RNA 2: 23-31.
56. MacDonald CC, McMahon KW. 2010. Tissue-specific mechanisms of alternative polyadenylation: Testis, brain, and beyond. Wiley Interdiscip Rev RNA 1: 494-501.
57. Malik S, Bagla S, Chaurasia P, Duan Z, Bhaumik SR. 2008. Elongating RNA polymerase II is disassembled through specific degradation of its largest but not other subunits in response to DNA damage in vivo. J Biol Chem 283: 6897-6905.
58. Mandart E. 1998. Effects of mutations in the Saccharomyces cerevisiae RNA14 gene on the abundance and polyadenylation of its transcripts. Mol Gen Genet 258: 16-25.
59. Martin G, Gruber AR, Keller W, Zavolan M. 2012. Genome-wide analysis of pre-mRNA 39 end processing reveals a decisive role of human cleavage factor I in the regulation of 39 UTR length. Cell Rep 1: 753-763.
60. Mayr C, Bartel DP. 2009. Widespread shortening of 39UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
61. Millevoi S, Vagner S. 2010. Molecular mechanisms of eukaryotic pre-mRNA 39 end processing regulation. Nucleic Acids Res 38: 2757-2774.
62. Munoz MJ, Perez Santangelo MS, Paronetto MP, de la Mata M, Pelisch F, Boireau S, Glover-Cutter K, Ben-Dov C, Blaustein M, Lozano JJ, et al. 2009.DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 137: 708-720.
63. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M. 2008.The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320: 1344-1349.
64. Nazeer FI, Devany E, Mohammed S, Fonseca D, Akukwe B, Taveras C, Kleiman FE. 2011. p53 inhibits mRNA 39 processing through its interaction with the CstF/BARD1 complex. Oncogene 30: 3073-3083.
65. Neilson JR, Sandberg R. 2010. Heterogeneity in mammalian RNA 39 end formation. Exp Cell Res 316: 1357-1364.
66. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Muhlemann O. 2010. Nonsense-mediated mRNA decay in human cells: Mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67: 677-700.
67. Ozsolak F, Kapranov P, Foissac S, Kim SW, Fishilevich E, Monaghan AP, John B, Milos PM. 2010. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 143: 1018-1029.
68. Pan Z, Zhang H, Hague LK, Lee JY, Lutz CS, Tian B. 2006. An intronic polyadenylation site in human and mouse CstF-77 genes suggests an evolutionarily conserved regulatory mechanism. Gene 366: 325-334.
69. Parker R. 2012. RNA degradation in Saccharomyces cerevisae. Genetics 191: 671-702.
70. Pinto PA, Henriques T, Freitas MO, Martins T, Domingues RG, Wyrzykowska PS, Coelho PA, Carmo AM, Sunkel CE, Proudfoot NJ, et al. 2011. RNA polymerase II kinetics in polo polyadenylation signal selection. EMBO J 30: 2431-2444.
71. Putnam CD, Jaehnig EJ, Kolodner RD. 2009. Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae. DNA Repair (Amst) 8: 974-982.
72. Reinke A, Chen JC, Aronova S, Powers T. 2006. Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p. J Biol Chem 281: 31616-31626.
73. Rio DC, Ares JM, Hannon GJ, Nilsen TW. 2011. Purification of RNA from natural sources. In RNA: A laboratory manual, pp. 180-185. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
74. Runner VM, Podolny V, Buratowski S. 2008. The Rpb4 subunit of RNA polymerase II contributes to cotranscriptional recruitment of 39 processing factors. Mol Cell Biol 28: 1883-1891.
75. Sabisz M, Skladanowski A. 2008. Modulation of cellular response to anticancer treatment by caffeine: Inhibition of cell cycle checkpoints, DNA repair and more. Curr Pharm Biotechnol 9: 325-336.
76. Saguez C, Schmid M, Olesen JR, Ghazy MA, Qu X, Poulsen MB, Nasser T, Moore C, Jensen TH. 2008. Nuclear mRNA surveillance in THO/sub2 mutants is triggered by inefficient polyadenylation. Mol Cell 31: 91-103.
77. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. 2008. Proliferating cells express mRNAs with shortened 39 untranslated regions and fewer microRNA target sites. Science 320: 1643-1647.
78. Shepard PJ, Choi EA, Lu J, Flanagan LA, Hertel KJ, Shi Y. 2011. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-seq. RNA 17: 761-772.
79. Shi Y. 2012. Alternative polyadenylation: New insights from global analyses. RNA 18: 2105-2117.
80. Singh P, Alley TL, Wright SM, Kamdar S, Schott W, Wilpan RY, Mills KD, Graber JH. 2009. Global changes in processing of mRNA 39 untranslated regions characterize clinically distinct cancer subtypes. Cancer Res 69: 9422-9430.
81. Smibert P, Miura P, Westholm JO, Shenker S, May G, Duff MO, Zhang D, Eads BD, Carlson J, Brown JB, et al. 2012. Global patterns of tissuespecific alternative polyadenylation in Drosophila. Cell Rep 1: 277-289.
82. Sparks KA, Dieckmann CL. 1998. Regulation of poly(A) site choice of several yeast mRNAs. Nucleic Acids Res 26: 4676-4687.
83. Sparks KA, Mayer SA, Dieckmann CL. 1997. Premature 39-end formation of CBP1 mRNA results in the downregulation of cytochrome b mRNA during the induction of respiration in Saccharomyces cerevisiae. Mol Cell Biol 17: 4199-4207.
84. Spriggs KA, Bushell M, Willis AE. 2010. Translational regulation of gene expression during conditions of cell stress. Mol Cell 40: 228-237.
85. Ulitsky I, Shkumatava A, Jan CH, Subtelny AO, Koppstein D, Bell GW, Sive H, Bartel DP. 2012. Extensive alternative polyadenylation during zebrafish development. Genome Res 22: 2054-2066.
86. van Helden J, del Olmo M, Perez-Ortin JE. 2000. Statistical analysis of yeast genomic downstream sequences reveals putative polyadenylation signals. Nucleic Acids Res 28: 1000-1010.
87. Wilson MA, Meaux S, van Hoof A. 2008. Diverse aberrancies target yeast mRNAs to cytoplasmic mRNA surveillance pathways. Biochim Biophys Acta 1779: 550-557.
88. Wong CM, Qiu H, Hu C, Dong J, Hinnebusch AG. 2007. Yeast cap binding complex impedes recruitment of cleavage factor IA to weak termination sites. Mol Cell Biol 27: 6520-6531.
89. Woudstra EC, Gilbert C, Fellows J, Jansen L, Brouwer J, Erdjument-Bromage H, Tempst P, Svejstrup JQ. 2002. A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature 415: 929-933.
90. Yan J, Marr TG. 2005. Computational analysis of 39-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. Genome Res 15: 369-375.
91. Yao C, Biesinger J, Wan J, Weng L, Xing Y, Xie X, Shi Y. 2012. Transcriptomewide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc Natl Acad Sci 109: 18773-18778.
92. Yassour M, Kaplan T, Fraser HB, Levin JZ, Pfiffner J, Adiconis X, Schroth G, Luo S, Khrebtukova I, Gnirke A, et al. 2009. Ab initio construction of a eukaryotic transcriptome by massively parallel mRNA sequencing. Proc Natl Acad Sci 106: 3264-3269.
93. Yoon OK, Brem RB. 2010. Noncanonical transcript forms in yeast and their regulation during environmental stress. RNA 16: 1256-1267.
94. Yu L, Volkert MR. 2013.UV damage regulates alternative polyadenylation of the RPB2 gene in yeast. Nucleic Acids Res 41: 3104-3114.
95. Zhang H, Hu J, Recce M, Tian B. 2005. PolyA-DB: A database for mammalian mRNA polyadenylation. Nucleic Acids Res 33: D116-D120.
96. Zhang X, Virtanen A, Kleiman FE. 2010. To polyadenylate or to deadenylate: That is the question. Cell Cycle 9: 4437-4449.
97. Zhao J, Kessler M, Helmling S, O'Connor JP, Moore C. 1999. Pta1, a component of yeast CF II, is required for both cleavage and poly(A) addition of mRNA precursor. Mol Cell Biol 19: 7733-7740.